Quarterly results, guidance and margins, and the numbers companies would rather you skimmed.

Steven Madden shares jumped more than 7% after the footwear company beat Q2 expectations and raised its 2026 outlook. Adjusted EPS came in a

Procter & Gamble's fiscal 2027 outlook points to modest organic sales growth, according to RBC Capital Markets. But the first half of the ye

Swiss stocks edged lower as two major earnings reports pulled in opposite directions. Bachem surged on a strong 2026 sales outlook, while Bu

Altria's second-quarter results showed Marlboro volumes falling 7.4% and On! nicotine pouches sliding 4.2% as consumers traded down to cheap

Cigna raised its 2026 profit forecast after its pharmacy benefits arm Evernorth posted 6% sales growth to $61.47 billion. Faster adoption of

Solstice Advanced Materials raised its 2026 outlook after a strong second quarter, with sales jumping past $1.15 billion and earnings beatin

InterDigital beat Wall Street's Q2 expectations and raised its full-year 2026 outlook. Shares jumped over 7% in premarket trading Thursday.

SiriusXM reported a surprise gain of 22,000 self-pay subscribers, but higher memory chip costs pushed equipment revenue down 22%, causing a

Galderma now expects 2026 net sales to grow 19%-21% at constant currency, up from 17%-20%. RBC Capital Markets responded by raising its earn

Martin Marietta Materials reported better-than-expected second-quarter earnings and raised its annual revenue forecast. The building materia

Blue Owl Capital met profit expectations, but fundraising slowed as private-wealth investors reduced inflows into its credit funds. Equity f

Exelon reported Q2 adjusted earnings of 43 cents per share, a penny below analysts' estimates, despite a 10% revenue jump to $5.97 billion.